作者: Aditya K. Gupta , Maria Cernea
DOI: 10.1517/14656566.2016.1146687
关键词:
摘要: ABSTRACTIntroduction: Onychomycosis is a fungal nail infection that difficult to treat due poor accessibility of drugs into the plate. Although oral antifungals can reach apparatus more readily, these therapies may not be suitable or desirable for some patients (e.g., multiple medications immunocompromised). Efinaconazole 10% solution new topical antifungal recently approved and sold in Canada, United States Japan treatment mild-to-moderate toenail onychomycosis. has broad-spectrum activity against dermatophytes, nondermatophyte molds yeasts, high ungual penetration its low keratin binding properties.Areas covered: The objective this article summarize recent data regarding efficacy, safety pharmacokinetic properties efinaconazole onychomycosis.Expert opinion: safe effective onychomycosis used wide range b...